Gabelli Healthcare & Wellness Rx Trust Announces Annual Meeting of Shareholders on May 13, 2024
Ticker: GRX · Form: DEF 14A · Filed: Mar 22, 2024 · CIK: 1391437
| Field | Detail |
|---|---|
| Company | Gabelli Healthcare & Wellnessrx Trust (GRX) |
| Form Type | DEF 14A |
| Filed Date | Mar 22, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $1,000, $0.001, $36,440, $32,158, $71,364 |
| Sentiment | neutral |
Sentiment: neutral
Topics: Proxy Statement, Annual Meeting, Shareholder Election, Trustees, Gabelli Healthcare
TL;DR
<b>Gabelli Healthcare & Wellness Rx Trust is holding its Annual Shareholder Meeting on May 13, 2024, to elect four Trustees.</b>
AI Summary
Gabelli Healthcare & WellnessRx Trust (GRX) filed a Proxy Statement (DEF 14A) with the SEC on March 22, 2024. The Gabelli Healthcare & Wellness Rx Trust will hold its Annual Meeting of Shareholders on May 13, 2024. The meeting will take place at 9:45 a.m. ET at GAMCO Investors, Inc. in Rye, New York, and virtually via Internet webcast. The primary purpose of the meeting is to elect four Trustees of the Fund. The filing is a Definitive Proxy Statement (DEF 14A) filed on March 22, 2024. The company's fiscal year ends on December 31.
Why It Matters
For investors and stakeholders tracking Gabelli Healthcare & WellnessRx Trust, this filing contains several important signals. This meeting is a key governance event where shareholders have the opportunity to influence the fund's leadership by electing Trustees. The dual format (in-person and virtual) aims to increase shareholder participation in the election process and other fund matters.
Risk Assessment
Risk Level: low — Gabelli Healthcare & WellnessRx Trust shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational concerns indicated.
Analyst Insight
Shareholders should review the proxy materials to make informed decisions regarding the election of Trustees.
Key Numbers
- May 13, 2024 — Annual Meeting Date (Date of Annual Meeting of Shareholders)
- 9:45 a.m. ET — Meeting Time (Time of Annual Meeting)
- four — Trustees to Elect (Number of Trustees to be elected at the meeting)
- 2024-03-22 — Filing Date (Date the DEF 14A was filed)
Key Players & Entities
- Gabelli Healthcare & Wellness Rx Trust (company) — Registrant name
- May 13, 2024 (date) — Date of Annual Meeting
- GAMCO Investors, Inc. (company) — Location of in-person meeting
- Rye, New York (location) — Address of meeting
- four (number) — Number of Trustees to be elected
- March 22, 2024 (date) — Filing date
- Delaware (location) — State of incorporation
- December 31 (date) — Fiscal year end
FAQ
When did Gabelli Healthcare & WellnessRx Trust file this DEF 14A?
Gabelli Healthcare & WellnessRx Trust filed this Proxy Statement (DEF 14A) with the SEC on March 22, 2024.
What is a DEF 14A filing?
A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by Gabelli Healthcare & WellnessRx Trust (GRX).
Where can I read the original DEF 14A filing from Gabelli Healthcare & WellnessRx Trust?
You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by Gabelli Healthcare & WellnessRx Trust.
What are the key takeaways from Gabelli Healthcare & WellnessRx Trust's DEF 14A?
Gabelli Healthcare & WellnessRx Trust filed this DEF 14A on March 22, 2024. Key takeaways: The Gabelli Healthcare & Wellness Rx Trust will hold its Annual Meeting of Shareholders on May 13, 2024.. The meeting will take place at 9:45 a.m. ET at GAMCO Investors, Inc. in Rye, New York, and virtually via Internet webcast.. The primary purpose of the meeting is to elect four Trustees of the Fund..
Is Gabelli Healthcare & WellnessRx Trust a risky investment based on this filing?
Based on this DEF 14A, Gabelli Healthcare & WellnessRx Trust presents a relatively low-risk profile. The filing is a routine proxy statement for an annual meeting, with no immediate financial or operational concerns indicated.
What should investors do after reading Gabelli Healthcare & WellnessRx Trust's DEF 14A?
Shareholders should review the proxy materials to make informed decisions regarding the election of Trustees. The overall sentiment from this filing is neutral.
How does Gabelli Healthcare & WellnessRx Trust compare to its industry peers?
The Gabelli Healthcare & Wellness Rx Trust is a closed-end management investment company. Its primary focus is on investing in companies within the healthcare and wellness sectors.
Are there regulatory concerns for Gabelli Healthcare & WellnessRx Trust?
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
Industry Context
The Gabelli Healthcare & Wellness Rx Trust is a closed-end management investment company. Its primary focus is on investing in companies within the healthcare and wellness sectors.
Regulatory Implications
The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies from shareholders.
What Investors Should Do
- Review the proxy statement for details on Trustee nominees and voting procedures.
- Vote on the election of four Trustees.
- Attend the Annual Meeting virtually or in person to stay informed about fund governance.
Key Dates
- 2024-05-13: Annual Meeting of Shareholders — Election of Trustees and other shareholder matters.
- 2024-03-22: DEF 14A Filing — Definitive Proxy Statement filed with the SEC.
Year-Over-Year Comparison
This is a DEF 14A filing for the annual meeting, indicating a routine governance process rather than a change from a previous filing type.
Filing Stats: 4,672 words · 19 min read · ~16 pages · Grade level 11.2 · Accepted 2024-03-21 20:03:34
Key Financial Figures
- $1,000 — tion of proxies for an estimated fee of $1,000 plus reimbursement of expenses. The Fun
- $0.001 — t outstanding: common shares, par value $0.001 per share (Common Shares''), and prefer
- $36,440 — ivate investment partnerships: (i) KBS- $36,440 and $32,158, (ii) KBS III- $71,364 and
- $32,158 — ment partnerships: (i) KBS- $36,440 and $32,158, (ii) KBS III- $71,364 and $64,336. (
- $71,364 — KBS- $36,440 and $32,158, (ii) KBS III- $71,364 and $64,336. (9) On September 9, 2015
- $64,336 — and $32,158, (ii) KBS III- $71,364 and $64,336. (9) On September 9, 2015, Mr. Zizza
- $150,000 — the SEC's findings and allegation, paid $150,000 and agreed to cease and desist committi
Filing Documents
- grx-html7537_def14a.htm (DEF 14A) — 260KB
- proxy001.jpg (GRAPHIC) — 548KB
- proxy002.jpg (GRAPHIC) — 772KB
- proxy003.jpg (GRAPHIC) — 552KB
- proxy004.jpg (GRAPHIC) — 772KB
- proxy005.jpg (GRAPHIC) — 552KB
- proxy006.jpg (GRAPHIC) — 772KB
- 0001133228-24-002418.txt ( ) — 9797KB
- ecf-20240403.xsd (EX-101.SCH) — 3KB
- ecf-20240403_def.xml (EX-101.DEF) — 3KB
- ecf-20240403_lab.xml (EX-101.LAB) — 2KB
- ecf-20240403_pre.xml (EX-101.PRE) — 2KB
- grx-html7537_def14a_htm.xml (XML) — 13KB
From the Filing
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to Sec. 240.14a-12 The Gabelli Healthcare & Wellness Rx Trust (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. 1) Title of each class of securities to which transaction applies: 2) Aggregate number of securities to which transaction applies: 3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11(set forth the amount on which the filing fee is calculated and state how it was determined): 4) Proposed maximum aggregate value of transaction: 5) Total fee paid: Fee paid previously with preliminary materials. Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. 1) Amount Previously Paid: 2) Form, Schedule or Registration 3) Filing Party: 4) Date Filed: THE GABELLI HEALTHCARE & WELLNESS Rx TRUST One Corporate Center Rye, New York 10580-1422 (914) 921-5070 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS To Be Held on May 13, 2024 To the Shareholders of THE GABELLI HEALTHCARE & WELLNESS Rx TRUST Notice is hereby given that the Annual Meeting of Shareholders of The Gabelli Healthcare & Wellness Rx Trust, a Delaware statutory trust (the Fund''), will be held on Monday, May 13, 2024, at 9:45 a.m., ET, at GAMCO Investors, Inc., One Corporate Center, 401 Theodore Fremd Avenue, Rye, New York, 10580 and virtually by Internet webcast (the Meeting''), and at any adjournments or postponements thereof for the following purposes: 1. To elect four (4), Trustees of the Fund to be elected by the holders of the Fund's common shares and holders of its 5.20% Series E Cumulative Preferred Shares and 5.20% Series G Cumulative Preferred Shares (together, Preferred Shares''), voting together as a single class; and 2. To consider and vote upon such other matters, including adjournments, as may properly come before said Meeting or any adjournments or postponements thereof. These items are discussed in greater detail in the attached Proxy Statement. We are conducting a "hybrid" meeting - you may attend in person or virtually. Whether or not you plan to attend the Meeting in person, shareholders must register in advance by submitting the required information to the Fund at: http://Gabelli.com/CEFAnnualMeeting. Following registration, a shareholder will be provided with instructions regarding how to access the virtual Meeting, including the link for the Meeting. Requests for registration must be received no later than 5:00 p.m., ET, on May 12, 2024. Shareholders will receive an email confirming their registration and providing instructions for participating in the Meeting. Any questions should be directed to CEFProxy@gabelli.com. The close of business on March 15, 2024, has been fixed as the record date for the determination of shareholders entitled to notice of and to vote at the Meeting and any adjournments or postponements thereof. YOUR VOTE IS IMPORTANT REGARDLESS OF THE SIZE OF YOUR HOLDINGS IN THE FUND. WE ENCOURAGE YOU TO VOTE YOUR PROXY IN ADVANCE OF THE MEETING, EVEN IF YOU PLAN TO ATTEND THE MEETING. SHAREHOLDERS MAY AUTHORIZE THEIR PROXY BY TELEPHONE OR THE INTERNET. ALTERNATIVELY, SHAREHOLDERS MAY SUBMIT VOTING INSTRUCTIONS BY SIGNING AND DATING THE PROXY CARD AND RETURNING IT IN THE ACCOMPANYING POSTAGE-PAID ENVELOPE. By Order of the Board of Trustees, PETER GOLDSTEIN Secretary April 3, 2024 INSTRUCTIONS FOR SIGNING PROXY CARDS TO BE RETURNED BY MAIL The following general rules for signing proxy cards may be of assistance to you and avoid the time and expense to the Fund involved in validating your vote if you fail to properly sign your proxy card. 1. Individual Accounts: Sign your name exactly as it appears in the registration on the proxy card. 2. Joint Accounts: Either party may sign, but the name of the party signing should conform exactly to the name shown in the registration. 3. All Other Accounts: The capacity of the individuals signing the proxy card should be indicated unless it is reflected in the form of registration. For example: Registration Valid Signature Corporate Accounts (1) ABC Corp. ABC Corp., John Doe, Treasurer (2) ABC Corp. John Doe, Tr